Absci is trading 5.2% up today at $8.34, extending a sharp rally that began in late June following positive data for its ABS-201 hair loss therapy.
- The stock recently reached new 52-week highs, supported by bullish analyst actions and sustained investor interest in its clinical pipeline.
- Today's gains appear driven by broader market momentum and a risk-on environment, as major indices trade higher despite a lack of fresh company-specific news.
- The move continues a trend of strong performance that has pushed the stock to multiple new highs in recent weeks.